Back to Search
KENNETH TACK, MD
MD
Infectious Disease Physician
NPI: 1932985850Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
4301043465(MI)
Research & Publications (20)
Metals in marine environment (mollusc Patella sp., fish Labrus bergylta, crustacean Cancer pagurus, beach sand) in a nuclear area, the North Cotentin (France).
PMID 19452254·Environ Monit Assess·2010
7-preclinical
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
PMID 19072714·Clin Infect Dis·2009
3-trial
Bioaccessibility, solid phase distribution, and speciation of Sb in soils and in digestive fluids.
PMID 19027930·Chemosphere·2009
8-other
Bioaccessibility of lead in high carbonate soils.
PMID 17654152·J Environ Sci Health A Tox Hazard Subst Environ Eng·2007
8-other
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
PMID 17913720·J Antimicrob Chemother·2007
4-observational
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
PMID 16447103·Clin Infect Dis·2006
4-observational
Open-label, multicentre, emergency-use study of clinafloxacin (CI-960) in the treatment of patients with serious life-threatening infections.
PMID 11932150·Int J Antimicrob Agents·2002
5-case
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
PMID 11906496·Clin Microbiol Infect·2002
3-trial
Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients.
PMID 11170945·Clin Infect Dis·2001
3-trial
A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.
PMID 11760164·Scand J Infect Dis·2001
3-trial
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
PMID 11158750·Antimicrob Agents Chemother·2001
3-trial
Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
PMID 11141229·Ann Surg·2001
3-trial
Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children.
PMID 11144398·Pediatr Infect Dis J·2000
3-trial
Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy.
PMID 11144397·Pediatr Infect Dis J·2000
3-trial
Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media.
PMID 11144396·Pediatr Infect Dis J·2000
3-trial
International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
PMID 10689211·Int J Infect Dis·2000
3-trial
A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
PMID 10954955·Int J Clin Pract·2000
3-trial
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
PMID 10945508·Clin Ther·2000
3-trial
Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
PMID 10837440·J Antimicrob Chemother·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10366 STONEY POINT DR
SOUTH LYON, MI 48178 - Phone
- (810) 355-8281
Quick Facts
- NPI
- 1932985850
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile